Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Faergemann

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|September 21, 2002
Medical historyJan Faergemann
Clinical Microbiology Reviews|October 5, 2002
Atopic dermatitis and fungiJan Faergemann
Periodontology 2000|January 21, 2009
Facial skin infectionsJan Faergemann, Gunnar Dahlén
Acta Dermato-Venereologica|March 28, 2009
Effect of pentane-1,5-diol and propane-1,2-diol on percutaneous absorption of terbinafineHanne Evenbratt, Jan Faergemann
Expert Opinion on Investigational Drugs|March 28, 2008
A comparison of pentane-1,5-diol to other diols for use in dermatologyJeanette Jacobsson Sundberg, Jan Faergemann
Acta Dermato-Venereologica|November 5, 2014
A retrospective analysis of skin bacterial colonisation, susceptibility and resistance in atopic dermatitis and impetigo patientsLouai A Salah, Jan Faergemann
Acta Dermato-Venereologica|June 8, 2010
Antimicrobial activity of topical skin pharmaceuticals - an in vitro studyMikael Alsterholm, Nahid Karami, Jan Faergemann
Acta Dermato-Venereologica|September 8, 2009
In vitro activity of chlorhexidine and pentane-1,5-diol and their combination on Candida albicans, Staphylococcus aureus and Propionibacterium acnesNahid Karami, Mikael Alsterholm, Jan Faergemann
Acta Dermato-Venereologica|July 26, 2005
The in vitro activity of pentane-1,5-diol against aerobic bacteria. A new antimicrobial agent for topical usage?Jan Faergemann, Thomas Hedner, Peter Larsson
Expert Opinion on Pharmacotherapy|June 15, 2007
A new ketoconazole topical gel formulation in seborrhoeic dermatitis: an updated review of the mechanismJan Faergemann, M Borgers, H Degreef
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|September 21, 2002
Medical historyJan Faergemann
Clinical Microbiology Reviews|October 5, 2002
Atopic dermatitis and fungiJan Faergemann
Periodontology 2000|January 21, 2009
Facial skin infectionsJan Faergemann, Gunnar Dahlén
Acta Dermato-Venereologica|March 28, 2009
Effect of pentane-1,5-diol and propane-1,2-diol on percutaneous absorption of terbinafineHanne Evenbratt, Jan Faergemann
Expert Opinion on Investigational Drugs|March 28, 2008
A comparison of pentane-1,5-diol to other diols for use in dermatologyJeanette Jacobsson Sundberg, Jan Faergemann
Acta Dermato-Venereologica|November 5, 2014
A retrospective analysis of skin bacterial colonisation, susceptibility and resistance in atopic dermatitis and impetigo patientsLouai A Salah, Jan Faergemann
Acta Dermato-Venereologica|June 8, 2010
Antimicrobial activity of topical skin pharmaceuticals - an in vitro studyMikael Alsterholm, Nahid Karami, Jan Faergemann
Acta Dermato-Venereologica|September 8, 2009
In vitro activity of chlorhexidine and pentane-1,5-diol and their combination on Candida albicans, Staphylococcus aureus and Propionibacterium acnesNahid Karami, Mikael Alsterholm, Jan Faergemann
Acta Dermato-Venereologica|July 26, 2005
The in vitro activity of pentane-1,5-diol against aerobic bacteria. A new antimicrobial agent for topical usage?Jan Faergemann, Thomas Hedner, Peter Larsson
Expert Opinion on Pharmacotherapy|June 15, 2007
A new ketoconazole topical gel formulation in seborrhoeic dermatitis: an updated review of the mechanismJan Faergemann, M Borgers, H Degreef
Pageof 5